Company / Profit Margin
Aligos Therapeutics, Inc. Profit Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Profit Margin
-1106.7%
FY2025
5-year range
-3633.7% / -1106.7%
FY2023-FY2025
Trend
+69.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -1551.4% to -1106.7% over the past 2 years.
Based on SEC 10-K filings.
-1106.7% in FY2025.
Improved from -1551.4% to -1106.7% over the past 2 years.
Profit Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, profit margin increased 69.5% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -8.07 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Profit MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -1106.7% | +69.5% |
| FY2024 | -3633.7% | -134.2% |
| FY2023 | -1551.4% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026